Feb 2, 2026
Industry Report – February 2026
The Industry Report in reply-all shares a selection of recent news featuring UPMC Enterprises, our portfolio companies, and partnerships.
This edition includes stories about our investment in Precede Biosciences, Ouro Medicine’s FDA fast track designation, RxAnte’s strategic growth investment from Primus Capital, and biopharma insights from Matthias Kleinz in an interview with MedCity News.
Keep an eye on UPMC Enterprises’ News webpage for the latest industry stories.
UPMC Enterprises
Avista Therapeutics
BrainCheck
Butterfly Network
Carta Healthcare
Ouro Medicines
Precede Biosciences
sovaSage
RxAnte
Sempre Health
Penguin Ai


